The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

被引：0

作者：

Sharmin, Sifat ^{[1
,2
]}

Roos, Izanne ^{[1
,3
]}

Simpson-Yap, Steve ^{[1
,4
,5
]}

Malpas, Charles ^{[1
,3
]}

Lechner-Scott, Jeannette ^{[6
]}

Buzzard, Katherine ^{[7
]}

Skibina, Olga ^{[7
]}

van der Walt, Anneke ^{[8
]}

Butzkueven, Helmut ^{[8
]}

Kermode, Allan ^{[9
]}

Butler, Ernest ^{[10
]}

Barnett, Michael ^{[10
]}

Hodgkinson, Suzanne ^{[11
]}

McCombe, Pamela ^{[12
,13
,14
]}

Taylor, Bruce ^{[15
]}

Slee, Mark ^{[16
]}

Macdonell, Richard ^{[17
]}

Garber, Justin ^{[18
]}

Shaw, Cameron ^{[19
]}

Shuey, Neil ^{[20
]}

Massey, Jennifer ^{[21
]}

Hardy, Todd ^{[22
]}

Parratt, John ^{[23
]}

Kalincik, Tomas ^{[1
,3
]}

机构：

[1] Univ Melbourne, Dept Med, CORe, Melbourne, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Neuroimmunol Ctr, Melbourne, Australia

[3] Royal Melbourne Hosp, Dept Neurol, Melbourne MS Ctr, Melbourne, Australia

[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Australia

[5] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia

[6] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, Australia

[7] Box Hill Hosp, Dept Neurol, Melbourne, Australia

[8] Alfred Hosp, Dept Neurol, Melbourne, Australia

[9] Univ Western Australia, Perron Inst, Nedlands, Australia

[10] Monash Med Ctr, Melbourne, Australia

[11] Brain & Mind Ctr, Sydney, NSW, Australia

[12] Liverpool Hosp, Sydney, Australia

[13] Univ Queensland, Brisbane, Australia

[14] Royal Brisbane & Womens Hosp, Brisbane, Australia

[15] Royal Hobart Hosp, Hobart, Australia

[16] Flinders Univ S Australia, Adelaide, SA, Australia

[17] Austin Hlth, Melbourne, Australia

[18] Westmead Hosp, Sydney, Australia

[19] Geelong Hosp, Geelong, Australia

[20] St Vincents Hosp, Fitzroy, Australia

[21] St Vincents Hosp Sydney, Sydney, Australia

[22] Concord Repatriat Gen Hosp, Sydney, Australia

[23] Royal North Shore Hosp, Sydney, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期

关键词：

secondary progressive multiple sclerosis; disease modifying therapy; latitude; geography; health expenditure;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：6 / 6

页数：1

共 50 条

[21] Analysis of potentially modifiable risk factors of multiple sclerosis
Lipska, Julia
AKTUALNOSCI NEUROLOGICZNE, 2024, 24 (02): : 59 - 63
[22] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
Harding-Forrester, Sam
Roos, Izanne
Sharmin, Sifat
Diouf, Ibrahima
Malpas, Charles
Nguyen, Ai-Lan
Moradi, Nahid
Horakova, Dana
Havrdova, Eva Kubala
Patti, Francesco
Ayuso, Guillermo Izquierdo
Madueno, Sara Eichau
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Onofrj, Marco
Lugaresi, Alessandra
Grand'Maison, Francois
Weinstock-Guttman, Bianca
Amato, Maria Pia
Grammond, Pierre
Gerlach, Oliver
Ozakbas, Serkan
Sola, Patrizia
Ferraro, Diana
Butzkueven, Helmut
Lechner-Scott, Jeannette
Boz, Cavit
Alroughani, Raed
Van Pesch, Vincent
Cartechini, Elisabetta
Terzi, Murat
Maimone, Davide
Ramo-Tello, Cristina
Spitaleri, Daniele Litterio A.
Kappos, Ludwig
Yamout, Bassem
Sa, Maria Jose
Slee, Mark
Morgado, Yolanda Blanco
Bergamaschi, Roberto
Butler, Ernest
Iuliano, Gerardo
Granella, Franco
Sidhom, Youssef
Gouider, Riadh
Ampapa, Radek
Van Wijmeersch, Bart
Karabudak, Rana
Prevost, Julie
NEUROLOGY, 2021, 96 (15)
[23] Cognition in secondary progressive multiple sclerosis(SPMS)
Doshi, A.
De Angelis, F.
Muhlert, N.
Prados, F.
Stutters, J.
Macmanus, D.
Wheeler-Kingshott, C. A. Gandini
Cicarelli, O.
Barkhof, F.
Chataway, J.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 562 - 563
[24] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
Lesley J. Scott
CNS Drugs, 2020, 34 : 1191 - 1200
[25] Management of Secondary-Progressive Multiple Sclerosis
Gavin Giovannoni
CNS Drugs, 2004, 18 : 653 - 669
[26] Prospects of siponimod in secondary progressive multiple sclerosis
McGinley, Marisa
Fox, Robert J.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
[27] Therapeutic approaches to secondary progressive multiple sclerosis
Lublin, FD
MULTIPLE SCLEROSIS, 2002, 8 (01): : 88 - 90
[28] Immunopathology of secondary-progressive multiple sclerosis
Prineas, JW
Kwon, EE
Cho, ES
Sharer, LR
Barnett, MH
Oleszak, EL
Hoffman, B
Morgan, BP
ANNALS OF NEUROLOGY, 2001, 50 (05) : 646 - 657
[29] Interferon beta for secondary progressive multiple sclerosis
La Mantia, Loredana
Vacchi, Laura
Di Pietrantonj, Carlo
Ebers, George
Rovaris, Marco
Fredrikson, Sten
Filippini, Graziella
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
[30] Cognitive reserve in secondary progressive multiple sclerosis
Sumowski, James F.
Chiaravalloti, Nancy
Leavitt, Victoria M.
DeLuca, John
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (10) : 1454 - 1458

← 1 2 3 4 5 →